TNGX - Company ID 0001819133
The table below shows Tango Therapeutics, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $112.28M | $69.53M | $66.39M | $59.97M | $142.75M | $1.31M |
| Short-term investments | $230.86M | $188.39M | $270.50M | $306.17M | $342.51M | - |
| Receivables | - | - | $2.00M | $2.00M | $2.00M | - |
| Inventory | - | - | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $353.76M |
| $266.34M |
| $346.54M |
| $375.27M |
| $492.34M |
| $1.50M |
| Property, plant & equipment | $6.87M | $8.10M | $9.91M | $10.88M | $4.83M | - |
| Goodwill | - | - | - | - | - | - |
| Total assets | $398.69M | $316.49M | $402.57M | $436.47M | $500.15M | $168.31M |
| Accounts payable | $1.18M | $1.60M | $2.79M | $4.45M | $3.23M | - |
| Total current liabilities | $21.68M | $38.17M | $45.94M | $55.55M | $40.69M | $114.35K |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $52.51M | $116.97M | $149.46M | $186.99M | $155.41M | $5.95M |
| Retained earnings | -$603.15M | -$501.56M | -$371.26M | -$269.51M | -$161.34M | -$123.05K |
| Total equity | $346.18M | $199.52M | $253.11M | $249.48M | $344.75M | $5.00M |